A dense inflammatory reaction in the vicinity of HER2-rich and TNBC-type breast tumors is an effort to facilitate aromatase expression and estrogen synthesis, supporting the regulatory improvement of these poorly differentiated cancers [8]. Here, CYP19A1 is linked to cancer.